Long-term data on efficacy and safety of adalimumab in Behçet's disease.

T B van der Houwen, B Humer,T O Missotten,A A H J Thiadens,P M van Hagen,J A M van Laar

Clinical immunology (Orlando, Fla.)（2023）

引用 2|浏览18

暂无评分

摘要

Our study illustrates durable long-term efficacy of adalimumab treatment in patients with BD. In our patient cohort long-term adalimumab treatment is safe, with a low incidence of serious adverse events.

查看译文

关键词

Adalimumab,Behçet's disease,Long term,Safety,Treatment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要